Transcatheter Aortic Valve Replacement
If you have been diagnosed with severe aortic stenosis and are considered to be intermediate or higher risk for open heart surgery, Transcatheter Aortic Valve Replacement (TAVR) may be an alternative for you.
Aortic valve stenosis is a serious condition. Severe aortic stenosis is a narrowing of your aortic valve opening that does not allow normal blood flow. Those who have aortic valve stenosis may feel chest pain or tightness, shortness of breath and have difficulty exerting themselves, particularly when exercising.
Without aortic valve replacement, patients with severe aortic valve stenosis have high mortality and a short life expectancy once symptoms develop. The transcatheter heart valve is delivered via a catheter-based approach typically without incision and without the use of cardiopulmonary bypass. This offers patients a therapeutic option that is less invasive while performing just as well as open heart surgery.
Not all patients are well suited for TAVR. Deciding between TAVR and surgical options like open heart surgery or other minimally invasive valve surgeries requires an experienced heart team evaluating you. Our goal is to offer you a personalized approach, selecting the procedure that we believe is best suited for you with the best possible outcome.
Experienced Heart Team
At Billings Clinic, our heart team takes a rigorous approach to patient care.
- Our TAVR program is built on a foundation of multi-disciplinary experience.
- Billings Clinic has the highest volume TAVR program in the region, since starting the program in May 2016.
- Our procedural team consists of two heart surgeons, two interventional cardiologists and echo specialists.
- We have done over 12,000 open heart operations.
- Our interventional team performs more than 2,500 interventional heart procedures every year.
- Our physicians have been involved with transcatheter technology from the initial investigations in the United States with the latest valve models.
Together with our outstanding valve clinic coordinators, our colleagues from our cardiovascular division, anesthesiologists and radiologists, we are striving to offer the latest leading edge therapy to our patients and communities.
TAVR Informational Videos
Four-video playlist includes: Path to Treatment, Talking to Your Doctor About Severe Aortic Stenosis, Treatment Options, How Does TAVR Work
For additional information about aortic valve stenosis and TAVR you visit www.newheartvalve.com.
FDA Approval, Number of Procedures Performed, Risks
TAVR Approval by the FDA
In November 2011, the U.S. Food and Drug Administration (FDA) approved the SAPIEN Transcatheter Heart Valve for the treatment of patients with severe native aortic valve stenosis who have been:
- determined by a cardiac surgeon to be inoperable for open aortic valve replacement
- and in whom existing co-morbidities would not preclude the expected benefit from correction of the aortic stenosis
The Centers for Medicare and Medicaid Services (CMS) approved it for coverage in May 2012. In August 2016, the FDA approved the SAPIEN Transcatheter Valve for patients who are deemed at an intermediate risk for surgery.
How long have TAVR procedures been performed?
The first successful TAVR procedure was performed in France on April 16, 2002 by Dr. Alain Cribier. The TAVR has been commercially available in Europe since 2007 and in the United States since 2011.
Risks of the TAVR procedure
There are still risks associated with TAVR along with surgical aortic valve replacement. These should be taken into consideration when discussing the procedure with your cardiologist.